NEWS
NHS England names new executive team to lead transition
NHS England has announced the incoming team who will help lead the organisation’s transition into the Department of Health and Social Care.
The team – called the NHS
Transformation Executive Team – replaces the current NHS England Executive Group and will support ongoing business priorities, statutory functions and day-to-day delivery. Except for David Probert – the new Deputy Chief Executive Officer – all colleagues were in post on 1 April 2025 to support this critical work.
The new team – drawn from the existing executive and the wider NHS on secondment – has been appointed following discussion with the Secretary of State, Department of Health and Social Care senior officials, incoming chair Dr Penny Dash and NHS England’s Board. All appointments are subject to the approval of the Board. Permanent recruitment and appointments will be made when the future form and structure is clearer. The roles of Chief Operating Officer and Chief Delivery Officer will no longer exist in the transformation structure. New roles include two Co-Medical Directors: Claire Fuller for primary care and Meghana Pandit
for secondary care. Further new posts are a Financial Reset and Accountability Director, filled by Glen Burley, and Elective Care, Cancer and Diagnostics Director, filled by Mark Cubbon. Other positions are: Chief Nursing Officer – Duncan Burton; Chief Financial Officer – Elizabeth O’Mahony. Glen Burley, Mark Cubbon and David
Probert will continue to do their Trust roles alongside their new roles on the Transformation Executive Team. Professor Stephen Powis will remain in post as National Medical Director until early July and will work with Meghana Pandit and Claire Fuller over the coming weeks to finalise arrangements for the medical directorate.
Other medical roles are: Clinical
Transformation Director – Vin Diwakar; Urgent and Emergency Care Director – Sarah-Jane Marsh; National Director of Primary Care and Community Services – Dr. Amanda Doyle. Seven Regional Directors will report into Jim Mackey as Chief Executive, as will Navina Evans (Chief Workforce, Training and Education Officer) and Chris Hopson (Chief Strategy Officer), and a new substantive Chief Digital Officer will be recruited as soon as possible.
RCPath Fellowship for IBMS Past President
Previous IBMS President and Clinical Pathology Lead and Lead Healthcare Scientist Debra Padgett has been awarded an Honorary Fellowship from The Royal College of Pathologists (RCPath) in recognition of her outstanding contributions to pathology and biomedical science.
Debra commented: “I am truly
honoured and humbled to receive the Honorary Fellowship from The Royal College of Pathologists. This recognition reflects not only my personal journey but also the invaluable collaboration between RCPath and the Institute of Biomedical Science in championing the vital role of biomedical scientists in pathology.” During her time as President and beyond, Debra has highlighted the critical
role of biomedical scientists in diagnosis, treatment, and medical innovation, underscoring the importance of strong partnerships in advancing the profession. She also emphasises the development of advanced roles for biomedical scientists as a key solution to workforce challenges, ensuring better patient outcomes and a stronger healthcare system.
WWW.PATHOLOGYINPRACTICE.COM APRIL 2025 IVD solutions through partnership
MAST URI® CONNECT
The Connected Solution for Urine Microbiology
• Direct Susceptibility Testing - Results in 18 hours
• Phenotypic Results Analysis - ID, AST and AMR
• End-to-End Sample Traceability
• Integrated EUCAST-aligned Reading Rules
• New Front-End Automation
Making urinalysis futURI®
stic
Up to 95% of urines reported in 24 hours
Contact us today for more information
sales@mast-group.com
www.mast-group.com
11
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56